In Brief: AHCPR PSA study

This article was originally published in The Gray Sheet

05 Jan 1998
News

Executive Summary

AHCPR PSA study: Agency for Health Care Policy and Research is seeking information on prostate-specific antigen test utility, costs, specific indications and appropriate patient population for a review of past, current and planned research related to PSA testing. According to a Dec. 22 Federal Register notice, AHCPR plans to make a recommendation following completion of the assessment to the Health Care Financing Administration regarding a Medicare coverage policy for the test...

Existing Subscriber? Sign in to continue reading.

New to Medtech Insight? Start a free trial today!

Table
View full table

ASK THE ANALYST
Email

Print
Bookmark
Share

Tags:

You must sign in to use this functionality

Authentication.SignIn.HeadSignInHeader

MT009344

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel

MT009344

All set! This article has been sent to my@email.address.

All fields are required. For multiple recipients, separate email addresses with a semicolon.

Please Note: Only individuals with an active subscription will be able to access the full article. All other readers will be directed to the abstract and would need to subscribe.

In Brief: AHCPR PSA study

News

Executive Summary

You must sign in to use this functionality

Authentication.SignIn.HeadSignInHeader

Register

Ask The Analyst

Email Article

Sign In To Set a Search Alert